🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#DYK there are over 10 million people living with #ParkinsonsDisease worldwide? This #ParkinsonsAwarenessMonth, access helpful resources provided by Parkinson's Foundation: bit.ly/4c9PDDq

Chad Swanson, Chief Development Officer, joined the “Improving the Therapeutic Potential of Immunotherapies in AD” session at #ADPD2025, where experts came together to discuss the latest research and strategies in slowing disease progression. We stand alongside the

We’re looking forward to attending the American Academy of Neurology 2025 annual meeting, where we’ll participate in discussions on the latest advancements in neurology and connect with neuroscience professionals from around the world. Learn more about #AANAM here: bit.ly/3QWl7Dj

We closed the book on a successful #ADPD2025. The insightful discussions and collaborative sessions we had with experts in the field fuel our commitment to driving research forward and advancing treatment options in #AlzheimersDisease and #ParkinsonsDisease.

We’ll be attending EMN's 6th Annual Network Meeting tomorrow in Athens! What better place than the birthplace of philosophy to join leading minds in the hematology community for insightful discussions on #amyloidosis? Learn more: bit.ly/3RDJhCN #EMN2025

Attending the EMN 6th Annual Network Meeting? Be sure to check out our poster showcasing data from our Phase 3 VITAL #clinicaltrial in AL #amyloidosis.

The road to an AL #amyloidosis diagnosis is complex. Ambiguous symptoms often lead patients to various specialists before finding answers. At Prothena, we remain committed to advancing amyloidosis research. Learn more: bit.ly/45sSPGQ

Our mission is clear: to make a meaningful impact on the millions of people worldwide affected by neurodegenerative and rare peripheral amyloid diseases. Listen as Randy Fawcett shares what motivates him to contribute to our important work. #ProthenaProud

An #AlzheimersDisease diagnosis can be overwhelming, not only for patients but also for their loved ones. Visit the Alzheimer's Association website to access helpful patient resources to navigate the challenges that come with this neurodegenerative disease: bit.ly/4k16JGy

From presenting #AlzheimersDisease biomarker data, taking part in a forum discussion, to engaging with patient advocacy groups and other key stakeholders, Prothenians were proud to be part of #ADPD25’s dynamic exchange. Learn more about our experience: bit.ly/3RIVypO

The Alzheimer's Association has released its 2025 #AlzheimersDisease Facts and Figures report, providing a comprehensive look into the evolving public perception of #Alzheimers, early detection and diagnosis. Learn more: bit.ly/43aRi8N

On May 14, Amyloidosis Research Consortium is hosting a webinar exploring the patient and caregiver experience in AL #amyloidosis — covering diagnostic challenges and ways to improve care. Learn more and register here: bit.ly/3EZhMkq

This #MothersDay, we’re highlighting Prothenian and mom of four, Yvonne Tchrakian. At Prothena, Yvonne found what she had been missing: purpose — and a workplace that supports both career and motherhood. #ProthenaProud

Patient and caregiver stories aren’t just powerful, they’re essential to driving connection, understanding, and change. Hear from Linda, Donna, and Mike as they reflect on the role of hope, both in their own lives and in the future of AL #amyloidosis: bit.ly/4jWfcer

On #ClinicalTrialsDay, we celebrate and honor the people at the heart of clinical research. Thank you to the patients, investigators, study teams, and researchers who make progress possible.

#Alzheimers disease impacts more than just memory – it also affects the emotional, physical, and daily lives of both patients and their caregivers. Alzheimer's Foundation of America's TODAY magazine is a valuable resource, offering expert advice and helpful tips for those navigating the realities of

This Alzheimer’s & Brain Awareness Month (#ABAM), we recognize the millions affected by #AlzheimersDisease and shine a light on the importance of brain health, early detection, and ongoing research. Visit the Alzheimer's Association website to access helpful resources:

Understanding brain health is key to recognizing the impact of #AlzheimersDisease. This Alzheimer’s and Brain Awareness Month, explore the Alzheimer's Association interactive brain tour to see how Alzheimer’s affects memory and learn how you can support brain health:

Today, we are excited to announce that our partner Roche will advance prasinezumab into Phase 3 development in early-stage Parkinson’s disease. Prasinezumab has the potential to be the first disease-modifying treatment option for the millions of individuals living with